ICLIO ACCC Member Survey

Question Title

* 1. How familiar are you with the therapeutic concept of Immuno-Oncology, specific Immuno-Oncology drugs/biologics coming to market, and the potential clinical applications of these drugs/biologics? Please rate your understanding on a scale of 1 (not at all familiar) to 5 (very familiar).

Not at all familiar

Slightly familiar

Somewhat familiar

Moderately familiar

Extremely familiar

Not at all familiar

Slightly familiar

Somewhat familiar

Moderately familiar

Extremely familiar

	Not at all important	Low importance	Neutral	Very important	Extremely important
Clinical applications of I-O	Clinical applications of I-O Not at all important	Clinical applications of I-O Low importance	Clinical applications of I-O Neutral	Clinical applications of I-O Very important	Clinical applications of I-O Extremely important
Evidence, Data, and Publication updates with regards to I-O	Evidence, Data, and Publication updates with regards to I-O Not at all important	Evidence, Data, and Publication updates with regards to I-O Low importance	Evidence, Data, and Publication updates with regards to I-O Neutral	Evidence, Data, and Publication updates with regards to I-O Very important	Evidence, Data, and Publication updates with regards to I-O Extremely important
Coverage and Reimbursement issues in I-O	Coverage and Reimbursement issues in I-O Not at all important	Coverage and Reimbursement issues in I-O Low importance	Coverage and Reimbursement issues in I-O Neutral	Coverage and Reimbursement issues in I-O Very important	Coverage and Reimbursement issues in I-O Extremely important
Practice and operational management of I-O and I-O products	Practice and operational management of I-O and I-O products Not at all important	Practice and operational management of I-O and I-O products Low importance	Practice and operational management of I-O and I-O products Neutral	Practice and operational management of I-O and I-O products Very important	Practice and operational management of I-O and I-O products Extremely important
Patient access and financial impact of I-O	Patient access and financial impact of I-O Not at all important	Patient access and financial impact of I-O Low importance	Patient access and financial impact of I-O Neutral	Patient access and financial impact of I-O Very important	Patient access and financial impact of I-O Extremely important

Not at all important

Low importance

Neutral

Very important

Extremely important

Clinical applications of I-O

Clinical applications of I-O Not at all important

Clinical applications of I-O Low importance

Clinical applications of I-O Neutral

Clinical applications of I-O Very important

Clinical applications of I-O Extremely important

Evidence, Data, and Publication updates with regards to I-O

Evidence, Data, and Publication updates with regards to I-O Not at all important

Evidence, Data, and Publication updates with regards to I-O Low importance

Evidence, Data, and Publication updates with regards to I-O Neutral

Evidence, Data, and Publication updates with regards to I-O Very important

Evidence, Data, and Publication updates with regards to I-O Extremely important

Coverage and Reimbursement issues in I-O

Coverage and Reimbursement issues in I-O Not at all important

Coverage and Reimbursement issues in I-O Low importance

Coverage and Reimbursement issues in I-O Neutral

Coverage and Reimbursement issues in I-O Very important

Coverage and Reimbursement issues in I-O Extremely important

Practice and operational management of I-O and I-O products

Practice and operational management of I-O and I-O products Not at all important

Practice and operational management of I-O and I-O products Low importance

Practice and operational management of I-O and I-O products Neutral

Practice and operational management of I-O and I-O products Very important

Practice and operational management of I-O and I-O products Extremely important

Patient access and financial impact of I-O

Patient access and financial impact of I-O Not at all important

Patient access and financial impact of I-O Low importance

Patient access and financial impact of I-O Neutral

Patient access and financial impact of I-O Very important

Patient access and financial impact of I-O Extremely important

Question Title

* 3. Which of the following would you be likely to participate in to fulfill I-O educational needs? (Select all that apply)

Large national meeting

Small regional meeting

Online learning modules

Reading educational papers/articles

Access an expert call line with convenient hours of operation

Other (please specify)

	Not at all challenging	Slightly challenging	Moderately challenging	Very challenging	Extremely challenging
Patient education	Patient education Not at all challenging	Patient education Slightly challenging	Patient education Moderately challenging	Patient education Very challenging	Patient education Extremely challenging
Holding back or managing patient demand	Holding back or managing patient demand Not at all challenging	Holding back or managing patient demand Slightly challenging	Holding back or managing patient demand Moderately challenging	Holding back or managing patient demand Very challenging	Holding back or managing patient demand Extremely challenging
Expansion of indications for I-O agents	Expansion of indications for I-O agents Not at all challenging	Expansion of indications for I-O agents Slightly challenging	Expansion of indications for I-O agents Moderately challenging	Expansion of indications for I-O agents Very challenging	Expansion of indications for I-O agents Extremely challenging
Education and training of practice staff	Education and training of practice staff Not at all challenging	Education and training of practice staff Slightly challenging	Education and training of practice staff Moderately challenging	Education and training of practice staff Very challenging	Education and training of practice staff Extremely challenging
Managing side effects	Managing side effects Not at all challenging	Managing side effects Slightly challenging	Managing side effects Moderately challenging	Managing side effects Very challenging	Managing side effects Extremely challenging
Use of I-O agents in combination	Use of I-O agents in combination Not at all challenging	Use of I-O agents in combination Slightly challenging	Use of I-O agents in combination Moderately challenging	Use of I-O agents in combination Very challenging	Use of I-O agents in combination Extremely challenging
Coverage and reimbursement issues in I-O	Coverage and reimbursement issues in I-O Not at all challenging	Coverage and reimbursement issues in I-O Slightly challenging	Coverage and reimbursement issues in I-O Moderately challenging	Coverage and reimbursement issues in I-O Very challenging	Coverage and reimbursement issues in I-O Extremely challenging
Practice operations issues	Practice operations issues Not at all challenging	Practice operations issues Slightly challenging	Practice operations issues Moderately challenging	Practice operations issues Very challenging	Practice operations issues Extremely challenging

Not at all challenging

Slightly challenging

Moderately challenging

Very challenging

Extremely challenging

Patient education

Patient education Not at all challenging

Patient education Slightly challenging

Patient education Moderately challenging

Patient education Very challenging

Patient education Extremely challenging

Holding back or managing patient demand

Holding back or managing patient demand Not at all challenging

Holding back or managing patient demand Slightly challenging

Holding back or managing patient demand Moderately challenging

Holding back or managing patient demand Very challenging

Holding back or managing patient demand Extremely challenging

Expansion of indications for I-O agents

Expansion of indications for I-O agents Not at all challenging

Expansion of indications for I-O agents Slightly challenging

Expansion of indications for I-O agents Moderately challenging

Expansion of indications for I-O agents Very challenging

Expansion of indications for I-O agents Extremely challenging

Education and training of practice staff

Education and training of practice staff Not at all challenging

Education and training of practice staff Slightly challenging

Education and training of practice staff Moderately challenging

Education and training of practice staff Very challenging

Education and training of practice staff Extremely challenging

Managing side effects

Managing side effects Not at all challenging

Managing side effects Slightly challenging

Managing side effects Moderately challenging

Managing side effects Very challenging

Managing side effects Extremely challenging

Use of I-O agents in combination

Use of I-O agents in combination Not at all challenging

Use of I-O agents in combination Slightly challenging

Use of I-O agents in combination Moderately challenging

Use of I-O agents in combination Very challenging

Use of I-O agents in combination Extremely challenging

Coverage and reimbursement issues in I-O

Coverage and reimbursement issues in I-O Not at all challenging

Coverage and reimbursement issues in I-O Slightly challenging

Coverage and reimbursement issues in I-O Moderately challenging

Coverage and reimbursement issues in I-O Very challenging

Coverage and reimbursement issues in I-O Extremely challenging

Practice operations issues

Practice operations issues Not at all challenging

Practice operations issues Slightly challenging

Practice operations issues Moderately challenging

Practice operations issues Very challenging

Practice operations issues Extremely challenging

	Not at all important	Low importance	Neutral	Very important	Extremely important
Getting reimbursed for appropriate off-label use	Getting reimbursed for appropriate off-label use Not at all important	Getting reimbursed for appropriate off-label use Low importance	Getting reimbursed for appropriate off-label use Neutral	Getting reimbursed for appropriate off-label use Very important	Getting reimbursed for appropriate off-label use Extremely important
Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory)	Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Not at all important	Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Low importance	Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Neutral	Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Very important	Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Extremely important
Having I-O specific treatment information available to my practice	Having I-O specific treatment information available to my practice Not at all important	Having I-O specific treatment information available to my practice Low importance	Having I-O specific treatment information available to my practice Neutral	Having I-O specific treatment information available to my practice Very important	Having I-O specific treatment information available to my practice Extremely important
Having access to experts for consultation on issues	Having access to experts for consultation on issues Not at all important	Having access to experts for consultation on issues Low importance	Having access to experts for consultation on issues Neutral	Having access to experts for consultation on issues Very important	Having access to experts for consultation on issues Extremely important

Not at all important

Low importance

Neutral

Very important

Extremely important

Getting reimbursed for appropriate off-label use

Getting reimbursed for appropriate off-label use Not at all important

Getting reimbursed for appropriate off-label use Low importance

Getting reimbursed for appropriate off-label use Neutral

Getting reimbursed for appropriate off-label use Very important

Getting reimbursed for appropriate off-label use Extremely important

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory)

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Not at all important

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Low importance

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Neutral

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Very important

Having the ability to work directly with payers to explain unique aspects of I-O (e.g., delayed response, immunologic memory) Extremely important

Having I-O specific treatment information available to my practice

Having I-O specific treatment information available to my practice Not at all important

Having I-O specific treatment information available to my practice Low importance

Having I-O specific treatment information available to my practice Neutral

Having I-O specific treatment information available to my practice Very important

Having I-O specific treatment information available to my practice Extremely important

Having access to experts for consultation on issues

Having access to experts for consultation on issues Not at all important

Having access to experts for consultation on issues Low importance

Having access to experts for consultation on issues Neutral

Having access to experts for consultation on issues Very important

Having access to experts for consultation on issues Extremely important

ICLIO ACCC Member Survey

Question Title

* 1. How familiar are you with the therapeutic concept of Immuno-Oncology, specific Immuno-Oncology drugs/biologics coming to market, and the potential clinical applications of these drugs/biologics? Please rate your understanding on a scale of 1 (not at all familiar) to 5 (very familiar).

Question Title

* 2. In the following categories, what is the level of importance to you and your practice or cancer program with regards to educational needs of Immuno-Oncology (I-O)? (Select one per row)

Question Title

* 3. Which of the following would you be likely to participate in to fulfill I-O educational needs? (Select all that apply)

Question Title

* 4. In your opinion, what is the level of challenge for each of the following related to the introduction and application of I-O in patient treatment planning activities. (Select one per row)

Question Title

* 5. Please tell us how important the following issues are to your practice or cancer program: (Select one per row)

Question Title

* 6. Would you be interested in being invited to participate as a member of a clinical scholar cohort in I-O? Please select one of the responses below: